All Articles

Estrogen Receptor–Positive (ER+), Premenopausal, Metastatic Breast Cancer Treatment Journey: Consideration of Ovarian Function Suppression (OFS) Drug Therapy

Resources

The Academy of Oncology Nurse & Patient Navigators, with support from TerSera Therapeutics, is delighted to offer you a resource to assist with educating your premenopausal patients with estrogen receptor-positive metastatic breast cancer and their caregivers as they navigate through the treatment journey, including managing the effects of ovarian function suppression drug therapy.

Best Practices in Breast Cancer Therapy | OFS

Managing Clinical and Psychosocial Impacts of OFS

Best Practices

Video Library

Hear expert commentary on ovarian function suppression (OFS) side effect management, including strategies used to address psychosocial challenges affecting premenopausal breast cancer patients undergoing OFS.

Best Practices in Breast Cancer Therapy | OFS

Setting Patient Expectations of OFS Treatment

Best Practices

Video Library

Listen as a nurse navigator discusses ovarian function suppression (OFS) and the subsequent impact of OFS on premenopausal women with breast cancer.

Best Practices in Breast Cancer Therapy | OFS

Fertility Preservation and Benefits of OFS

Best Practices

Video Library

Polly Niravath, MD, discusses fertility preservation in premenopausal women with breast cancer who are undergoing ovarian function suppression (OFS) treatment.

Measuring the Value of Oncology Patient Navigation

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

The Editor’s Take

April 2024 Vol 15, No 4

Navigation brings value to modern healthcare practice, and the healthcare community is taking note.

The Role of the Nurse Navigator in Facilitating Molecular Testing via a Reference Laboratory in Non–Small Cell Lung Cancer: A Case Study

By Chelsea Bostelman, MSN, APRN, AGCNS-BC, OCN; Teresa Parent, RN, BSN, OCN; Shannon Elpers, BSN, RN; Chelsea Passwater, DNP, APRN, AGCNS-BC, OCN

Original Research

April 2024 Vol 15, No 4

To describe types of molecular testing and discuss considerations for their application in NSCLC to support the role of the nurse navigator in facilitating efficient molecular testing.

A Registered Nurse–Driven Survivorship Program

Original Research

April 2024 Vol 15, No 4

This institution transitioned the leadership of its survivorship program to a nurse navigator and achieved excellent results

Needs of Oncology Nurse Navigators Serving Young or Metastatic Breast Cancer Patients

Original Research

April 2024 Vol 15, No 4

Young women with breast cancer, as well as women with metastatic breast cancer, have unique needs as part of their treatment and survivorship plan. Researchers report on the needs of the oncology nurse navigators who serve these special populations.

Unlocking Insights Into Breast Cancer Treatment and Fertility Preservation: Understanding Counseling Impact, Techniques, and Patient Concerns

Web Exclusives

Breast cancer treatments pose significant fertility risks, emphasizing the importance of fertility counseling and preservation techniques, as highlighted by a study on young breast cancer patients.

Exploring the Role of OFS in Premenopausal HR-Positive/HER2-Positive Breast Cancer: Real-World Evidence and Prognostic Insights

Web Exclusives

Adding aromatase inhibitors to ovarian function suppression significantly improves invasive disease-free survival and underscores the importance of individualized treatment decisions based on clinicopathological factors.

All Articles

Page 23 of 283

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.